Condition

Type I Diabetes

ClinicalTrials.gov condition label

Clinical trials27
Recruiting2
Common interventions25
Lead sponsors shown15

Clinical trials

27 shown
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes MellitusNCT06964087 · 2026-04-10
RECRUITING
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)NCT06739811 · 2025-03-21
RECRUITING
Food is Medicine in Pediatric Patients With DiabetesNCT07535502 · 2026-10-05
NOT_YET_RECRUITING
How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at AltitudeNCT06242548 · 2023-06-02
COMPLETED
Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in BangladeshNCT06674135 · 2022-06-01
COMPLETED
Type 1 Diabetic Post Prandial Glycemia Evaluation Using an AlgorithmNCT05151770 · 2021-12-30
COMPLETED
Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 DiabetesNCT05035368 · 2021-09-30
WITHDRAWN
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041NCT04279613 · 2020-11-23
COMPLETED
Diabetes Inspired Culinary EducationNCT05160142 · 2019-09-05
COMPLETED
Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin PumpNCT03653533 · 2019-01-07
TERMINATED
Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy SubjectsNCT01843114 · 2015-01-12
COMPLETED
The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I DiabetesNCT02002130 · 2015-01-01
COMPLETED
Effects of Capros in Patients With Type-1 DiabetesNCT02634216 · 2015-01-01
COMPLETED
Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes PatientsNCT02117518 · 2014-05-01
UNKNOWN
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I DiabetesNCT01928329 · 2013-09-01
COMPLETED
Epigenetic Modifications of Diabetes Mellitus Type INCT01623388 · 2013-01-01
WITHDRAWN
The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral NeuropathyNCT02127762 · 2012-09-01
COMPLETED
A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet TransplantationNCT01652911 · 2012-06-01
TERMINATED
Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 DiabetesNCT01477476 · 2012-03-01
WITHDRAWN
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsNCT01398670 · 2012-02-01
WITHDRAWN
Immunosafety Study of Recombinant Human Insulins in Type 1 DiabeticsNCT01308437 · 2011-03-01
TERMINATED
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)NCT00999375 · 2009-09-18
COMPLETED
Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring DeviceNCT00361608 · 2008-07-01
WITHDRAWN
Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET ScanNCT00351650 · 2006-07-09
COMPLETED
Obesity and Metabolic Surgery in Patients With Type I DiabetesNCT02612493 · 2006-01-01
COMPLETED
Management of Type 1 Diabetes Among AdolescentsNCT00340639 · 2003-01-28
COMPLETED
Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic PatientsNCT01352663
WITHDRAWN

Common interventions

PlaceboOTHER2Active Oral GABA and Active GAD-alum injectionDRUG1AnakinraDRUG1Behavior ModificationBEHAVIORAL1biosimilar insulin glargineDRUG1blood drawingOTHER1CaprosDIETARY_SUPPLEMENT1Captor CGM Enlite®DEVICE1Community ServingsOTHER1DICEBEHAVIORAL1Dynamic Vessel AnalyzerOTHER1EarlySense ES 16DEVICE1EducationBEHAVIORAL1Exenatide (Bydureon®)DRUG1FDOCTDEVICE1GABA and Placebo GAD-alumDRUG1Implantable Insulin Pump SystemDEVICE1Insulin LisproBIOLOGICAL1LadarixinDRUG1Lantus®BIOLOGICAL1Measure of glycemia levels and comparison to algorithm predictionsOTHER1Mindfulness Based Stress ReductionBEHAVIORAL1MiniMed™ 640GDEVICE1NNC0361-0041DRUG1Novolin® (N or 70/30 with R)BIOLOGICAL1

Trial status mix

COMPLETED14
WITHDRAWN6
TERMINATED3
RECRUITING2
NOT_YET_RECRUITING1
UNKNOWN1

Phase mix

NA7
PHASE26
PHASE13
PHASE33
EARLY_PHASE11
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.